PHASE I CLINICAL TRIAL TARGETING CD20+NON-HODGKIN'S LYMPHOMA (NHL) AFTER AUTOLOGOUS STEM CELL TRANSPLANT WITH ANTI-CD3 x ANTI-CD20 BISPECIFIC ANTIBODY ARMED T CELLS

被引：1
|
作者：
Lum, L. G. [1 ]
Thakur, A. [1 ]
Ratanatharathorn, V [1 ]
Al-Kadhimi, Z. [1 ]
Paul, E. [1 ]
Skuba, C. [2 ]
Steel, P. [1 ]
Ayash, L. [1 ]
Abidi, M. [1 ]
Wedge, J. [1 ]
Uberti, J. P. [1 ]
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
23
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [1] Phase I Dose Esclation of Activated T Cells (ATC) Armed with Anti-CD3 x Anti-CD20 Bispecific Antibody (CD20Bi) after Stem Cell Transplant (SCT) In Non-Hodgkin's Lymphoma (NHL)
    Lum, Lawrence G.
    Ratanatharathorn, Voravit
    Thakur, Archana
    Al-Kadhimi, Zaid
    Skuba, Cassara
    Paul, Elyse N.
    Steele, Patricia A.
    Ayash, Lois
    Abidi, Muneer H.
    Uberti, Joseph P.
    BLOOD, 2010, 116 (21) : 216 - 217
  • [2] Phase I trial of multiple infusions of autologous activated T cells with anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) after autologous peripheral blood stem cell transplant for nonHodgkins lymphoma to improve graft-vs-lymphoma effects
    Lum, Lawrence G.
    Uberti, Joseph P.
    Al-Kadhimi, Zaid
    Skuba, Cassara
    Steele, Pat
    Sandborg, Rebecca
    Ratanatharathorn, Voravit
    BLOOD, 2007, 110 (11) : 193B - 193B
  • [3] TARGETING MYELOMA STEM CELLS WITH T CELLS ARMED WITH ANTI-CD3 X ANTI-CD20 BISPECIFIC ANTIBODY (CD20BI) PRIOR TO ASCT LEADS TO DEVELOPMENT OF ANTI-MYELOMA IMMUNE RESPONSES POST AUTOLOGOUS STEM CELL TRANSPLANT THAT CAN BE BOOSTED WITH TARGETED T CELLS
    Lawrence, L. G.
    Archana, T.
    Muneer, A.
    Zaid, A-K
    Voravit, R.
    Jeffrey, Z.
    Lois, A.
    Elyse, P. N.
    Dana, S.
    Patricia, S. A.
    Karen, M.
    Joseph, U. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S259 - S259
  • [4] Immune consolidation after stem cell transplant for CD20+ nonhodgkin's lymphoma using multiple infusions of autologous activated T cells (ATC) with anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) to improve graft-vs-lymphoma effects
    Lum, LG
    Davol, P
    Colvin, G
    Rathore, R
    Ahedi, M
    Palushock, E
    Olsen, A
    Tarro, T
    Quesenbery, P
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 119 - 119
  • [5] Targeting CD20+ Rituxan resistant B-cells with anti-CD3 activated T cells (ATC) armed with anti-CD3 x anti-CD20 (CD20Bi)
    Gall, JM
    Grabert, RC
    Deavers, M
    Davoll, PA
    Lum, LG
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 35 - 35
  • [6] PHARMACOKINETICS AND EXPOSURE-RESPONSE FOR REGN1979, A BISPECIFIC ANTI-CD20 X ANTI-CD3 ANTIBODY, IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA.
    Yang, F.
    Zhu, M.
    Toroghi, M.
    Putluri, D.
    Yan, H.
    Davis, J.
    DiCioccio, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S120 - S120
  • [7] T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro
    Gall, JM
    Davol, PA
    Grabert, RC
    Deaver, M
    Lum, LG
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (04) : 452 - 459
  • [8] Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 X anti-CD3 bispecific diabody
    Xiong, DS
    Xu, YF
    Liu, HZ
    Peng, H
    Shao, XF
    Lai, ZZ
    Fan, DM
    Yang, M
    Han, JL
    Xie, Y
    Yang, CZ
    Zhu, ZQ
    CANCER LETTERS, 2002, 177 (01) : 29 - 39
  • [9] Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma
    Lu, Chia-Yen
    Chen, Gregory J.
    Tai, Pei-Han
    Yang, Yu-Chen
    Hsu, Yu-Shen
    Chang, Mingi
    Hsu, Chuan-Lung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (04) : 808 - 813
  • [10] Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma
    Patel, Krish
    Michot, Jean-Marie
    Chanan-Khan, Asher
    Ghesquieres, Herve
    Bouabdallah, Kamal
    Byrd, John C.
    Cartron, Guillaume
    Portell, Craig A.
    Solh, Melhem
    Tilly, Herve
    Wierda, William G.
    McGovern, Patricia
    Johnson, Chelsea
    Garcha, Raman
    Ribrag, Vincent
    Brisou, Gabriel
    Liebowitz, David
    Phillips, Tycel
    BLOOD, 2021, 138
12345